Recent studies from the LEV Foundation and Brian Kennedy’s team show that combining therapies targeting multiple age-related damages can significantly extend lifespan and healthspan in preclinic...
A new 12-week clinical trial investigates time-restricted eating’s effects on mitochondrial function and symptom onset in early-stage Huntington’s disease patients using advanced digital m...
A 12-week clinical trial investigates time-restricted eating’s safety and efficacy in early-stage Huntington’s disease, focusing on mitochondrial function and cognitive outcomes. Groundbre...
Exploring a 12-week clinical trial protocol for time-restricted eating in early-stage Huntington’s disease, focusing on mitochondrial function, autophagy, and cognitive improvements. A new 12-we...
A proposed 12-week clinical trial explores time-restricted eating’s potential benefits on mitochondrial function, autophagy, and cognitive performance in early-stage Huntington’s disease p...
